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CHOREA CAUSED BY UNRUPTURED 
ARTERIOVENOUS MALFORMATION: 
CASE REPORT AND REVIEW OF LITERATURE
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SUMMARY – Chorea is a movement disorder that can be caused by a large range of degenerative, 
vascular, metabolic and toxic disorders in basal ganglia. Arteriovenous malformations are rare vascular 
malformations the clinical presentation of which depends on the malformation characteristics and 
localization. Th ey are most commonly presented with intracranial hemorrhage, while focal neurologi-
cal defi cit is the rarest presentation. A case is reported of a 64-year-old female patient presented with 
hemichorea. Magnetic resonance imaging and digital subtraction angiography revealed the presence 
of arteriovenous malformation in the right temporal lobe.
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Introduction
Chorea is a movement disorder characterized by 
involuntary, purposeless, rapid movements of the 
limbs, trunk, neck and face. Chorea aff ecting one side 
of the body is called hemichorea. Diff erent causes, in-
cluding genetic, metabolic, pharmacological and struc-
tural, can lead to disturbances in basal ganglia, which 
leads to the loss of inhibition in subthalamic nucleus 
resulting in involuntary movements1-4. Huntington’s 
disease, an autosomal dominant neurodegenerative 
disorder, is the best known cause of chorea. Chorea as 
a symptom may occur as part of Wilson’s disease, be-
nign hereditary chorea, neuroacanthocytosis, and some 
other inherited diseases3,5. Autoimmune disorders in-
cluding systemic lupus erythematosus, Sjögren’s syn-
drome and antiphospholipid syndrome may have cho-
rea in their clinical presentation6-9. Sydenham’s chorea 
occurs as a result of cross-reaction of antistreptococcal 
antibodies with basal ganglia neurons10. While some 
causes of chorea may manifest as hemichorea, it is still 
more often a result of certain processes localized in 
contralateral basal ganglia. Hemichorea may occur in 
patients with nonketotic hyperglycemia, and can also 
be part of the paraneoplastic syndrome3.
Arteriovenous malformations (AVM) of the brain 
are rare vascular malformations that are supposed to be 
of congenital origin11. Th eir angioarchitecture is com-
plex and includes arterial feeders, a net of dysplastic 
vessels, so-called nidus and draining veins12. Clinical 
presentation of AVM depends on hemodynamic char-
acteristics and topography of the malformation13.
We report a case of a female patient with an AVM 
in the temporal lobe who presented with hemichorea.
Case Report
A 64-year-old female patient came with choreic 
movements that she had noticed one month before she 
was admitted to the hospital. In addition, she noticed 
handedness of the left arm and temporary episodes of 
numbness of the left arm and left side of the face. Oc-
casionally, she observed tics of the left half of the face. 
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In the past medical history, for more than thirty years 
she had asserted temporary occipital headaches ac-
companied with nausea and urge to vomit. Her neuro-
logical status was predominated by choreiform move-
ments, along with discrete weakness of the left hand, 
atypical left plantar response, and dysmetria of the left 
hand. Tandem gait was poor. Laboratory tests showed 
elevated levels of cholesterol and triglycerides, while 
other parameters, including glucose, were within the 
reference values. Ultrasound examination of vertebral 
arteries showed mild stenosis of both internal carotid 
arteries. Multislice computed tomography of the brain 
did not show any acute focal lesions, while magnetic 
resonance imaging (MRI) of the brain revealed a pro-
nounced tangle of punctiform tubular lesions of the 
fl ow void type, in the sense of tangle of small blood 
vessels, in the medial temporal lobe, the amygdala, and 
the right uncus. For objective evaluation of the de-
scribed lesion, we performed digital subtraction angi-
ography (DSA), which showed a plexiform arteriove-
nous malformation (AVM) in the right temporal lobe 
with numerous feeding arteries running from the lat-
eral thalamostriatal perforators, as well as from both 
trunks of the insular segment of the right middle cere-
bral artery (M2) (Fig. 1). Over two wide, varicose 
drainage veins, malformation drained to Galen’s vein 
and to the compound of the right transverse and sig-
moid sinus. Angiography of the left vertebral artery 
showed a malformation probably situated just over the 
right posterior communicating artery. Th e patient was 
referred to treatment with embolization and ‘gamma 
knife’ method.
Review of Literature
Th e most common inherited cause of chorea is 
Huntington’s disease, caused by abnormal expansion 
of CAG trinucleotide on chromosome 4p16. Although 
it usually occurs in middle age, Huntington’s disease 
may occur in the seventh or eighth decade of life as a 
result of the small number of CAG trinucleotide re-
peats. In these cases, family history may be negative, 
either because of misdiagnosis, or because the carrier 
of the mutant gene had died before the onset of symp-
toms3,14. Vascular insult is the most common sporadic 
cause of chorea15. Th e incidence of chorea following 
stroke ranges from 0.5% to 1.3%15,16.
Although movement disorders occur frequently in 
neurological practice, they are rarely the result of 
AVM. Lobo-Antunes et al. have described two pa-
tients with tremor and dystonia caused by AVM in the 
contralateral basal ganglia, thalamus and mesencepha-
lon, one patient with torticollis and AVM in the pos-
terior thalamus, and another one with retrocollis and 
AVM in the parietal lobe. In two patients, the presence 
of AVM was detected just after its rupture and subse-
quent subarachnoid hemorrhage. Selective emboliza-
tion was performed in one patient with tremor, but 
without clinical improvement17. Krauss et al. report on 
six patients, of which one had hemidystonia caused by 
AVM in the contralateral frontoparietal lobe. Two pa-
tients had unilateral tremor associated with AVM in 
the contralateral frontal lobe. One patient developed 
hemidystonia and hemichorea-hemiballism after 
bleeding of temporo-occipital AVM, and two patients 
had focal hemidystonia caused by hemorrhage from 
AVM in the basal ganglia. Five patients were operated 
on and the movement disorder resolved in one of 
them18.
In the available literature, diff erent movement dis-
orders are reported as a result of AVM, either ruptured 
or not, while hemichorea is reported once as a result of 
ruptured AVM. In our case, hemichorea occurred as a 
result of unruptured AVM in the medial part of the 
temporal lobe, which makes this case unique.
Fig. 1. Digital subtraction angiography shows plexiform 
arteriovenous malformation in the right temporal lobe.
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Discussion
Hemichorea can be caused by a large range of de-
generative, vascular, metabolic and toxic disturbances 
in the contralateral basal ganglia19,20. Among these, 
acute vascular incident is the most common cause21. 
Th e pathophysiological mechanism leading to hemi-
chorea is complex and not yet completely understood. 
According to the widely accepted hypothesis, hyperki-
netic movement disorders occur due to the loss of sub-
thalamic nucleus control on the internal segment of 
the globus pallidus (GPi), which leads to disinhibition 
of the thalamus. Furthermore, decreased striatal in-
hibitory activity on the external part of the globus pal-
lidus (GPe) results in increased inhibitory activity of 
the GPe, which in turn results in overinhibition of the 
subthalamic nucleus leading to hypoactivity of the 
GPi. Th is decreased inhibitory activity from basal gan-
glia neurons leads to unrestrained thalamocortical 
drive and the appearance of dyskinesias22-24.
Arteriovenous malformations most commonly 
present with intracranial hemorrhage, epilepsy, head-
ache, or focal neurologic defi cits25. Intracranial hemor-
rhage is the most common clinical presentation of 
AVM (53%)26. Annual risk of hemorrhage is estimated 
to 2%-4%, and the risk of re-rupture is increased to up 
to 18% in the fi rst year after initial bleeding27,28. Epi-
lepsy is the fi rst clinical manifestation of AVM in 
16%-53% of cases29. In the majority of these cases, sei-
zures are focal, while generalized seizures occur in 30% 
of cases30. Chronic headache occurs in 7%-48% of pa-
tients with AVM29. According to a survey conducted 
in 1999 by the Arteriovenous Malformation Study 
Group, no headache characteristics such as frequency, 
duration and severity can indicate the presence of 
AVM31. Focal neurologic defi cit is the rarest clinical 
presentation of AVM. According to a study that in-
cluded 1289 patients with brain AVM, reversible focal 
neurologic defi cits were present in 8%, persistent neu-
rologic defi cits in 7%, and progressive neurologic defi -
cits in 5% of patients26.
Although AVM is assumed to be of congenital ori-
gin, most of them are clinically presented later in life. 
Th e mean age at clinical presentation is in the third or 
fourth decade of life, with equal sex distribution13,32. 
AVM may become symptomatic by several diff erent 
mechanisms. Th e fi rst one is hemorrhage, which may 
be subarachnoid, intraventricular, or in the brain pa-
renchyma. Secondly, the size of AVM may be such as 
to exert pressure upon certain parts of the brain (mass 
eff ect). Finally, a large volume of blood shunted 
through the AVM may result in so-called ‘steal phe-
nomenon’ that leads to temporary or permanent isch-
emia of neuronal structures17,18,32. Th e concept of ‘steal 
phenomenon’ has been recently challenged29. Al-
though most AVM are diagnosed after the onset of 
acute hemorrhage, epilepsy or focal neurologic defi cit, 
a growing number of AVM are found accidentally on 
imaging investigations prescribed for other reasons26,33. 
Computed tomography and MRI are used in diagnos-
ing AVM, but defi nitive diagnosis is based on DSA, 
which provides most information on the angioarchi-
tecture and hemodynamics malformations.
Certain characteristics of AVM are associated with 
an increased risk of hemorrhage, i.e. deep venous 
drainage, presence of aneurysm in the nidus or in the 
arterial feeder, and deep localization of AVM25,34. Oth-
er studies found no positive correlation of these factors 
with an increased risk of hemorrhage35, but most stud-
ies showed the risk of hemorrhage to increase with age, 
growing by about one-third with all decades of life34,35.
Arteriovenous malformations are classifi ed accord-
ing to Spetzler-Martin’s classifi cation in six grades. 
Th is classifi cation considers the size of the malforma-
tion, the proximity of the functional centers in the 
brain, so-called eloquent areas of the brain, and the 
type of venous drainage36. Also, this classifi cation is 
widely used for the choice of therapy and to predict 
the outcome of certain therapeutic procedures. Grade 
VI represents inoperable AVM36. Considering thera-
peutic outcomes of certain grades of AVM, in 2011 
Spetzler and Ponce reclassifi ed Spetzler-Martin clas-
sifi cation into three groups: low surgical risk for grades 
I and II, intermediate surgical risk for grade III, and 
high risk for grades IV and V37.
Th ere are several treatment options for AVM, i.e. 
neurosurgical operations, stereotactic radiotherapy, 
and endovascular embolization38. Today, surgical man-
agement is recommended for grades I and II39, multi-
modality treatment for grade III, and observation is 
usually recommended for grades IV and V, except for 
patients with recurrent hemorrhage, progressive neu-
rologic defi cit, or medically intractable seizures caused 
by the AVM40. In patients with contraindications for 
surgery, stereotactic radiotherapy may be an eff ective 
way of treatment of AVM41. Unlike the immediate ef-
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fi cacy of surgery, the results of stereotactic radiothera-
py evolve over several years, during which the risk of 
hemorrhage persists, and the risk of adverse eff ects of 
radiation on the surrounding tissue should also be as-
sessed. Endovascular embolization is most commonly 
used as adjunctive therapy in the treatment of AVM, 
mainly to facilitate or make surgery or radiotherapy 
safer. To achieve desirable outcome of treatment of 
AVM, it is necessary to estimate the risk of an event 
due to the natural course of the disease against the risk 
of a particular therapeutic option38.
Th e case presented shows that a relatively common 
symptomatology such as movement disorder in the 
background may have a rare cause such as AVM. Care-
ful medical history and examination with neuroradio-
logical imaging are the key to successful diagnosis. In 
such cases, an interdisciplinary team of neurologists, 
neurosurgeons and neuroradiologists is required to 
make the best decision on the therapeutic choice that 
will have a favorable outcome for the patient.
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Sažetak
KOREA UZROKOVANA ARTERIOVENSKOM MALFORMACIJOM: 
PRIKAZ SLUČAJA I PREGLED LITERATURE
P. Jurinović, E. Jadrijević, A. Repić-Buličić i M. Titlić
Korea je poremećaj pokreta koji može biti uzrokovan velikim rasponom degenerativnih, vaskularnih, metaboličkih i 
 toksičnih poremećaja u bazalnim ganglijima. Arteriovenske malformacije su rijetke vaskularne malformacije klinička prezen-
tacija kojih ovisi o karakteristikama i lokalizaciji malformacije. Najčešće se prezentiraju intrakranijskom hemoragijom, a 
najrjeđe fokalnim neurološkim defi citom. Prikazujemo slučaj 64-godišnje bolesnice koja se prezentirala hemikoreom. Uči-
njena magnetska rezonanca i digitalna subtrakcijska angiografi ja otkrila je prisutnost arteriovenske malformacije u medijal-
nom dijelu desnog temporalnog režnja.
Ključne riječi: Korea; Pokretljivost, poremećaji; Bazalni gangliji, bolesti; Arteriovenske malformacije; Intrakranijska krvarenja; 
Prikazi slučaja
